Page last updated: 2024-10-24

chetomin and Glial Cell Tumors

chetomin has been researched along with Glial Cell Tumors in 2 studies

chetomin: C31H30N6O6S4, similar to epipolythiodioxopiperazines
chetomin : An organic heteropentacyclic compound of the class of epipolythiodioxopiperazine. Isolated from Chaetomium globosum and Farrowia seminuda, it exhibits immunosuppressive activity.

Research Excerpts

ExcerptRelevanceReference
"Although siRNA and chetomin show distinct modes of action, both attenuated the hypoxia-induced radioresistance of malignant glioma cell lines U251MG (DMF10: 1."7.76HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression. ( Bache, M; Hahnel, A; Kappler, M; Kessler, J; Rot, S; Vordermark, D; Wichmann, H, 2010)
"Although siRNA and chetomin show distinct modes of action, both attenuated the hypoxia-induced radioresistance of malignant glioma cell lines U251MG (DMF10: 1."3.76HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression. ( Bache, M; Hahnel, A; Kappler, M; Kessler, J; Rot, S; Vordermark, D; Wichmann, H, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, H1
Li, Y1
Shu, M1
Tang, J1
Huang, Y1
Zhou, Y1
Liang, Y1
Yan, G1
Kessler, J1
Hahnel, A1
Wichmann, H1
Rot, S1
Kappler, M1
Bache, M1
Vordermark, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Metformin and Neo-adjuvant Temozolomide and Hypofractionated Accelerated Limited-margin Radiotherapy Followed by Adjuvant Temozolomide in Patients With Glioblastoma Multiforme (M-HARTT STUDY)[NCT02780024]Phase 250 participants (Anticipated)Interventional2015-03-31Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for chetomin and Glial Cell Tumors

ArticleYear
Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas.
    The FEBS journal, 2009, Volume: 276, Issue:24

    Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Transformation, Neoplastic; Cobalt; Colforsin;

2009
HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
    BMC cancer, 2010, Nov-04, Volume: 10

    Topics: Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Carbonic Anhydrase IX; Carbonic Anhydrases; Ce

2010